Search by Drug Name or NDC
NDC 61314-0019-10 DORZOLAMIDE HYDROCHLORIDE 20 mg/mL Details
DORZOLAMIDE HYDROCHLORIDE 20 mg/mL
DORZOLAMIDE HYDROCHLORIDE is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is DORZOLAMIDE HYDROCHLORIDE.
MedlinePlus Drug Summary
Ophthalmic dorzolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Dorzolamide is in a class of medications called carbonic anhydrase inhibitors. It works by decreasing the pressure in the eye.
Related Packages: 61314-0019-10Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Dorzolamide Ophthalmic
Product Information
NDC | 61314-0019 |
---|---|
Product ID | 61314-019_764fec18-11c4-4320-a834-83c80c7040d2 |
Associated GPIs | 86802340102020 |
GCN Sequence Number | 023513 |
GCN Sequence Number Description | dorzolamide HCl DROPS 2 % OPHTHALMIC |
HIC3 | Q6G |
HIC3 Description | MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS |
GCN | 33380 |
HICL Sequence Number | 009896 |
HICL Sequence Number Description | DORZOLAMIDE HCL |
Brand/Generic | Generic |
Proprietary Name | DORZOLAMIDE HYDROCHLORIDE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | dorzolamide hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION/ DROPS |
Route | OPHTHALMIC |
Active Ingredient Strength | 20 |
Active Ingredient Units | mg/mL |
Substance Name | DORZOLAMIDE HYDROCHLORIDE |
Labeler Name | Sandoz Inc |
Pharmaceutical Class | Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA078981 |
Listing Certified Through | 2024-12-31 |
Package
NDC 61314-0019-10 (61314001910)
NDC Package Code | 61314-019-10 |
---|---|
Billing NDC | 61314001910 |
Package | 10 mL in 1 BOTTLE (61314-019-10) |
Marketing Start Date | 2009-06-01 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 1.41198 |
Pricing Unit | ML |
Effective Date | 2024-02-21 |
NDC Description | DORZOLAMIDE HCL 2% EYE DROPS |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1, 5 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis